Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Enzyme Inhib Med Chem ; 37(1): 2256-2264, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36000171

RESUMO

In searching for new molecular drug targets, Carbonic Anhydrases (CAs) have emerged as valuable targets in diverse diseases. CAs play critical functions in maintaining pH and CO2 homeostasis, metabolic pathways, and much more. So, it is becoming attractive for medicinal chemists to design novel inhibitors for this class of enzymes with improved potency and selectivity towards the different isoforms. In the present study, three sets of carboxylic acid derivatives 5a-q, 7a-b and 12a-c were designed, developed and evaluated for the hCA inhibitory effects against hCA I, II, IX and XII. Compounds 5l, 5m, and 5q elicited the highest inhibitory activities against hCA II, IX and XII. In summary, structural rigidification, regioisomerism and structural extension, all played obvious roles in the degree of hCA inhibition. This present work could be a good starting point for the design of more non-classical selective hCA inhibitors as potential targets for several diseases.


Assuntos
Inibidores da Anidrase Carbônica , Anidrases Carbônicas , Antígenos de Neoplasias/metabolismo , Anidrase Carbônica IX/metabolismo , Inibidores da Anidrase Carbônica/química , Anidrases Carbônicas/metabolismo , Ácidos Carboxílicos/farmacologia , Estrutura Molecular , Relação Estrutura-Atividade
2.
PLoS One ; 14(1): e0210478, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30699138

RESUMO

Bacterial diseases cause high mortality in Penaeus (Litopenaeus) vannamei postlarvae. Therefore, appropriate application of efficient therapeutic products is of vital importance for disease control. This study evaluated through in vitro analyses the antimicrobial effectiveness of commercial therapeutic products used for P. vannamei bacterial diseases and antibiotics against pathogenic Vibrio strains circulating in Ecuadorian hatcheries. Twenty strains were isolated from 31 larvae samples with high bacterial counts from 10 hatcheries collected during mortality events. The strains virulence was verified through challenge tests with Artemia franciscana nauplii and P. vannamei postlarvae. Through 16S rRNA sequence analysis, strains showed a great similarity to the Vibrio sequences reported as pathogens, with 95% belonging to the Harveyi clade. Through antibiograms and minimal inhibitory concentration (MIC) in vitro tests we found that furazolidone, ciprofloxacin, chloramphenicol, norfloxacin, nalidixic acid, florfenicol, fosfomycin and enrofloxacin inhibited the growth of all or most of the strains. Less efficient antibiotics were penicillin, oxytetracycline and tetracycline. A multiple antibiotic resistance (MAR) index of 0.23 showed some level of resistance to antibiotics, with two MAR prevalent patterns (Penicillin-Oxytetracycline and Penicillin-Oxytetracycline-Tetracycline). From a total of 16 natural products (five probiotics, nine organic acids and two essential oils), only three (one probiotic, one organic acid and one essential oil) were effective to control most of the strains. Shrimp producers can apply relatively simple in vitro analyses, such as those employed in this study, to help take adequate management decisions to reduce the impact of bacterial diseases and increase profit.


Assuntos
Antibacterianos/uso terapêutico , Aquicultura , Produtos Biológicos/uso terapêutico , Surtos de Doenças/prevenção & controle , Penaeidae/microbiologia , Vibrioses/tratamento farmacológico , Vibrioses/prevenção & controle , Vibrio/efeitos dos fármacos , Animais , Antibacterianos/farmacologia , Sequência de Bases , Produtos Biológicos/farmacologia , Ácidos Carboxílicos/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Resistência Microbiana a Medicamentos/efeitos dos fármacos , Equador/epidemiologia , Hemócitos/citologia , Hemócitos/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Óleos Voláteis/farmacologia , Penaeidae/citologia , Penaeidae/efeitos dos fármacos , Filogenia , Probióticos/farmacologia , RNA Ribossômico 16S/genética , Resultado do Tratamento , Vibrioses/epidemiologia , Vibrioses/virologia
3.
Avian Pathol ; 42(3): 268-75, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23600468

RESUMO

Organic acid products are widely used in the UK poultry industry as feed or water additives. Claims for Salmonella control are made for some of these products, but there are few studies comparing the anti-Salmonella effect of the various products in tests that reflect field application. The present studies examined the effects of 13 commercial blends (four water products and nine feed products) on Salmonella Enteritidis and Typhimurium strains. Initial screening, in nutrient broth, of all products with all strains revealed little variation between strains in respect of maximum inhibitory and bactericidal dilutions of each product. However, between the products there was wide and significant variation in the maximum inhibitory and bactericidal dilutions, spanning a 700-fold range in the case of bactericidal dilutions for feed-associated products. Further tests were performed, examining reductions in inoculated Salmonella numbers in various matrices (water, feed, soiled litter, crop and caecal contents) following the addition of the products at recommended inclusion rates. One product, incorporating formaldehyde in addition to organic acid, was consistently most active in all matrices, exceeding reductions associated with other products by 1 to 3 log units at most time points. Many products showed only modest anti-Salmonella activity, amounting to 0 or 1 log unit above negative controls at many time points, and the most active products were not the same in all matrices. Tap water appeared to enhance the ability of products to reduce Salmonella, in comparison with bottled mineral or river water.


Assuntos
Antibacterianos/farmacologia , Ácidos Carboxílicos/farmacologia , Doenças das Aves Domésticas/microbiologia , Doenças das Aves Domésticas/prevenção & controle , Salmonelose Animal/prevenção & controle , Salmonella enteritidis/efeitos dos fármacos , Salmonella typhimurium/efeitos dos fármacos , Animais , Formaldeído/farmacologia , Testes de Sensibilidade Microbiana , Aves Domésticas , Especificidade da Espécie , Água/farmacologia
4.
Parasitol Res ; 110(2): 1029-32, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-21826488

RESUMO

Traditionally, malachite green administrated as in-bath treatment was the most effective and common strategy used in freshwater aquaculture systems to control infections of the ciliate protozoan parasite Ichthyophthirius multifiliis Fouquet, 1876. After the ban of malachite green in the USA and Europe to be used in fish for human consumption, there has been extensive research destined to find efficacious replacements. Recently, peracetic acid-based compounds have demonstrated a strong cytotoxic effect in vitro and in vivo against I. multifiliis. In the present study, we tested the efficacy of a hydrogen peroxide, peracetic, acetic and peroctanoic acid-based formulation (HPPAPA) to eliminate the free-living stages of I. multifiliis (tomonts, cysts and theronts). The results obtained showed that the administration of low doses (8, 12 or 15 mg/l) of a specific HPPAPA-based product during a short window of exposure (60 min) kills nearly all free-living stages of I. multifiliis (theronts, tomonts and cysts) within the window of treatment (∼100% mortality for all the stages; one-way ANOVA, P ≤ 0.001). Of note, even the lowest concentration of HPPAPA tested (8 mg/l) was able to disrupt normal cyst development and therefore theront release. The demonstrated in vitro efficacy of the peracetic acid-based product tested on the present study suggests its great potential to control I. multifiliis infections in commercial aquacultural systems.


Assuntos
Antiprotozoários/farmacologia , Ácidos Carboxílicos/farmacologia , Peróxido de Hidrogênio/farmacologia , Hymenostomatida/efeitos dos fármacos , Oxidantes/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Testes de Sensibilidade Parasitária
5.
Curr Opin Investig Drugs ; 6(5): 545-58, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15912970

RESUMO

GlaxoSmithKline is developing cilomilast, a phosphodiesterase 4 inhibitor, for the potential treatment of chronic obstructive pulmonary disease. The compound has been assessed in phase III clinical trials.


Assuntos
Nitrilas/farmacologia , Nitrilas/uso terapêutico , Animais , Ácidos Carboxílicos/farmacologia , Ácidos Carboxílicos/uso terapêutico , Ácidos Cicloexanocarboxílicos , Indústria Farmacêutica/organização & administração , Humanos , Metanálise como Assunto , Doença Pulmonar Obstrutiva Crônica/tratamento farmacológico
6.
Toxicol Sci ; 61(1): 6-17, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11294969

RESUMO

The rates of cell proliferation and cell loss in conjunction with the differentiation status of a tissue are among the many factors contributing to carcinogenesis. Nongenotoxic (non-DNA reactive) chemicals may affect this balance by increasing proliferation through direct mitogenesis or through a regenerative response following loss of cells through cytotoxic (oncotic) or apoptotic necrosis. In a recent NTP study in Fischer rats and B6C3F(1) mice, the mycotoxin fumonisin B(1) caused renal carcinomas in male rats and liver cancer in female mice. In an earlier study in male BD-IX rats, fumonisin B(1) caused hepatic toxicity and hepatocellular carcinomas. An early effect of fumonisin B(1) exposure in these target organs is apoptosis. However, there is also some evidence of oncotic necrosis following fumonisin B(1) administration, especially in the liver. Induction of apoptosis may be a consequence of ceramide synthase inhibition and disruption of sphingolipid metabolism by fumonisin B(1). Fumonisin B(1) is not genotoxic in bacterial mutagenesis screens or in the rat liver unscheduled DNA-synthesis assay. Fumonisin B(1) may be the first example of an apparently nongenotoxic (non-DNA reactive) agent producing tumors through a mode of action involving apoptotic necrosis, atrophy, and consequent regeneration.


Assuntos
Apoptose , Ácidos Carboxílicos/metabolismo , Ácidos Carboxílicos/farmacologia , Ácidos Carboxílicos/farmacocinética , Ácidos Carboxílicos/toxicidade , DNA/metabolismo , Neoplasias Esofágicas/complicações , Fumonisinas , Neoplasias Renais/induzido quimicamente , Rim/efeitos dos fármacos , Neoplasias Hepáticas/induzido quimicamente , Fígado/efeitos dos fármacos , Esfingolipídeos/metabolismo , África/epidemiologia , Animais , China/epidemiologia , Tomada de Decisões , Neoplasias Esofágicas/induzido quimicamente , Neoplasias Esofágicas/epidemiologia , Feminino , Humanos , Masculino , Camundongos , Camundongos Endogâmicos , Micotoxinas/classificação , Micotoxinas/toxicidade , Ratos , Ratos Endogâmicos , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA